/ HemaCore
Business Services · Russia · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Научный Проезд д.20 стр.2, Moscow, Mosco...Phone Number
+7 4952582538Website
www.hemacore.comRevenue
$8.4 MillionIndustry
About / HemaCore
/ HemaCore Org Chart
Is / HemaCore your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if / HemaCore had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at / HemaCore
Check out if / HemaCore is spiking on competitors!
Check if / HemaCore has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when / HemaCore launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once / HemaCore has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on / HemaCore recently announced quarterly report
/ HemaCore, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at / HemaCore
Find more new buyers
Company Profile Activity
Activity Insights
/ HemaCore is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
/ HemaCore is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about / HemaCore.
/ HemaCore Tech Stack
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding / HemaCore
Hemacore specializes in the development of the Thrombodynamics platform, which provides a global test for the early diagnosis of blood coagulation disorders, identifying risks of bleeding and thrombosis. Their products and services are aimed at medical professionals, including those in obstetrics, gynecology, phlebology, oncology, intensive care, s... Read More